title: The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.
abstract: Myocilin variants, localized to the olfactomedin (OLF) domain, are linked to early-onset, inherited forms of open-angle glaucoma. Disease-causing myocilin variants accumulate within trabecular meshwork cells instead of being secreted to the trabecular extracellular matrix of the eye. We hypothesize that, like in other diseases of protein misfolding, aggregation and downstream pathogenesis originate from the compromised thermal stability of mutant myocilins. In an expansion of our pilot study of four mutants, we compare 21 additional purified OLF variants by using a fluorescence stability assay and investigate the secondary structure of the most stable variants by circular dichroism. Variants with lower melting temperatures are correlated with earlier glaucoma diagnoses. The chemical chaperone trimethylamine N-oxide is capable of restoring the stability of most, but not all, variants to wild-type (WT) levels. Interestingly, three reported OLF disease variants, A427T, G246R, and A445V, exhibited properties indistinguishable from those of WT OLF, but an increased apparent aggregation propensity in vitro relative to that of WT OLF suggests that biophysical factors other than thermal stability, such as kinetics and unfolding pathways, may also be involved in myocilin glaucoma pathogenesis. Similarly, no changes from WT OLF stability and secondary structure were detected for three annotated single-nucleotide polymorphism variants. Our work provides the first quantitative demonstration of compromised stability among many identified OLF variants and places myocilin glaucoma in the context of other diseases of protein misfolding.
authors: School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, United States.
authors: J Nicole
authors: JN
authors: Burns
authors: Katherine C
authors: KC
authors: Turnage
authors: Chandler A
authors: CA
authors: Walker
authors: Raquel L
authors: RL
authors: Lieberman
references: Oncogene. 2007 Apr 2;26(15):2226-42
references: 17401432
references: Annu Rev Biochem. 2009;78:959-91
references: 19298183
references: J Biol Chem. 2005 Aug 12;280(32):28917-26
references: 15944158
references: J Glaucoma. 2003 Jun;12(3):237-42
references: 12782842
references: Hum Mol Genet. 2009 Sep 1;18(17):3217-26
references: 19483195
references: Arch Ophthalmol. 2003 Aug;121(8):1172-80
references: 12912696
references: J Med Genet. 1998 Dec;35(12):989-92
references: 9863594
references: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1683-90
references: 17389500
references: J Biol Chem. 2010 Oct 1;285(40):30989-1001
references: 20663888
references: N Engl J Med. 2009 Mar 12;360(11):1113-24
references: 19279343
references: Exp Eye Res. 2009 Apr;88(4):704-12
references: 18804106
references: Lab Invest. 1999 Oct;79(10):1237-45
references: 10532587
references: Methods Mol Biol. 2010;628:1-20
references: 20238073
references: Prog Retin Eye Res. 2002 Jul;21(4):395-428
references: 12150989
references: Ophthalmology. 1998 Sep;105(9):1698-707
references: 9754180
references: Nat Rev Mol Cell Biol. 2005 Nov;6(11):891-8
references: 16167052
references: Nucleic Acids Res. 2007 Jul;35(Web Server issue):W649-52
references: 17452345
references: J Biol Chem. 2009 Jul 17;284(29):19159-63
references: 19395706
references: Invest Ophthalmol Vis Sci. 2008 May;49(5):1932-9
references: 18436825
references: Exp Biol Med (Maywood). 2009 Oct;234(10):1140-54
references: 19596823
references: N Engl J Med. 1998 Apr 9;338(15):1022-7
references: 9535666
references: Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13813-8
references: 16945909
references: Biochemistry. 1995 Oct 3;34(39):12884-91
references: 7548045
references: PLoS One. 2009;4(1):e4216
references: 19148291
references: J Biol Chem. 2010 Jun 18;285(25):19544-52
references: 20189984
references: Hum Mol Genet. 2001 Jan 15;10(2):117-25
references: 11152659
references: J Neurosci. 2006 Nov 15;26(46):11903-14
references: 17108164
references: J Med Genet. 2000 Apr;37(4):301-3
references: 10819638
references: Oncogene. 2000 Mar 2;19(10):1245-56
references: 10713666
references: Clin Cancer Res. 2006 Feb 15;12(4):1157-67
references: 16489069
references: Science. 1997 Jan 31;275(5300):668-70
references: 9005853
references: HFSP J. 2008 Dec;2(6):354-64
references: 19436494
references: Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2577-82
references: 10509652
references: PLoS Biol. 2008 Jul 29;6(7):e170
references: 18666828
references: Exp Eye Res. 2006 Jun;82(6):1030-6
references: 16297911
references: J Biol Chem. 1994 Jan 21;269(3):2283-91
references: 8294487
references: Mol Vis. 2007 Jul 13;13:1161-8
references: 17679945
references: Nat Genet. 1998 Aug;19(4):319-21
references: 9697688
references: Nat Protoc. 2007;2(9):2212-21
references: 17853878
references: Curr Opin Chem Biol. 2007 Aug;11(4):412-8
references: 17644022
references: Mol Vis. 1998 Oct 06;4:20
references: 9772276
references: Hum Mutat. 2003 Aug;22(2):179
references: 12872267
references: Hum Mol Genet. 1999 Nov;8(12):2221-8
references: 10545602
references: Hum Mol Genet. 2002 Sep 1;11(18):2077-90
references: 12189160
references: Exp Eye Res. 2010 Dec;91(6):901-8
references: 20932969
references: Exp Eye Res. 2006 Jun;82(6):1017-29
references: 16466712
references: Mol Vis. 2007 Apr 19;13:618-25
references: 17515882
references: Trends Biochem Sci. 2007 Feb;32(2):78-85
references: 17208444
references: Graefes Arch Clin Exp Ophthalmol. 2002 Jun;240(6):468-74
references: 12107514
references: Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R91-102
references: 14764620
references: Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3560-7
references: 15452063
references: ACS Chem Biol. 2010 May 21;5(5):477-87
references: 20334347
references: Am J Pathol. 2007 Jan;170(1):100-9
references: 17200186
references: Biochem Biophys Res Commun. 2003 Mar 14;302(3):554-61
references: 12615070
references: Am J Med Genet. 1998 Apr 13;76(5):438-45
references: 9556305
references: Exp Eye Res. 2006 Dec;83(6):1386-95
references: 16973161
references: Trends Endocrinol Metab. 2010 Nov;21(11):652-9
references: 20724178
references: Invest Ophthalmol Vis Sci. 2000 May;41(6):1386-91
references: 10798654
references: PLoS One. 2011 Jan 24;6(1):e16347
references: 21283635
references: Arch Ophthalmol. 2003 Jul;121(7):1034-8
references: 12860809
references: Mol Cell Biol. 2001 Nov;21(22):7707-13
references: 11604506
references: Hum Mol Genet. 1997 Nov;6(12):2091-7
references: 9328473
references: Lancet. 2004 May 22;363(9422):1711-20
references: 15158634
references: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14338-42
references: 9405613
references: Arch Ophthalmol. 2002 Sep;120(9):1189-97
references: 12215093
references: Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3743-9
references: 19234343
references: Am J Ophthalmol. 2000 Aug;130(2):165-77
references: 11004290
references: Annu Rev Biochem. 2008;77:557-82
references: 18410249
references: Hum Mol Genet. 1999 May;8(5):899-905
references: 10196380
references: Hum Mol Genet. 2004 Jun 1;13(11):1193-204
references: 15069026